Release Date: 21/02/24 16:13 Summary: Half Yearly Report - 31 Dec 2023 (Price Sensitive) Price Sensitive: Yes Download Document 478.95KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status